ADRB1 rs769049386: The Genetics of Natural Short Sleep
The rs769049386 variant is a rare genetic change in the ADRB1 gene associated with familial natural short sleep (FNSS2). This condition allows individuals to feel fully rested after sleeping significantly fewer hours than the average person.
What each genotype means
Typical sleep duration
You carry two copies of the common reference allele at this position in the ADRB1 gene. This genotype is associated with normal adrenergic signaling in sleep-wake circuits and standard physiological sleep requirements. It is not associated with the familial natural short sleep phenotype.
Carried by more than 99.99% of individuals across all major global populations.
Natural short sleep trait
You carry one copy of the rare missense variant (Ala187Val) linked to autosomal dominant familial natural short sleep 2. Published research suggests heterozygous carriers often function well on significantly less sleep (typically 4 to 6 hours per night) without daytime impairment, though expressivity can vary depending on individual genetic background. This trait is considered a benign physiological variation rather than a sleep disorder.
Extremely rare; observed in fewer than 1 in 20,000 individuals globally in population reference databases like gnomAD.
Natural short sleep (homozygous)
You carry two copies of the rare Ala187Val variant in ADRB1. While familial natural short sleep acts as a dominant trait where a single copy is sufficient to alter sleep duration, homozygous individuals have not been described in clinical cohorts. The exact phenotypic expression or potential broader adrenergic consequences of carrying two copies remain uncharacterized in published literature.
Exceptionally rare to virtually unobserved in general population databases.
Understanding the rs769049386 Variant
The variant rs769049386, also known as the Ala187Val (A187V) mutation, is a specific change in the DNA sequence of the ADRB1 gene. Located on chromosome 10, this missense mutation involves a single nucleotide substitution that results in an amino acid change from alanine to valine at position 187 of the beta-1 adrenergic receptor protein. This specific residue is located within the fourth transmembrane domain of the receptor, a region that is highly conserved across many different species, suggesting it plays a critical role in the protein's function. Because this variant is extremely rare, it is not typically found in standard genetic screening panels. It was first identified through linkage analysis and whole-exome sequencing in a large, multigenerational family where the short-sleep trait followed an autosomal dominant pattern of inheritance.
The Role of the ADRB1 Gene
The ADRB1 gene provides instructions for creating the beta-1 adrenergic receptor, a protein that binds to neurotransmitters like epinephrine and norepinephrine. While these receptors are well-known for their role in regulating heart rate and cardiac function, they are also expressed in the brain, particularly in the dorsal pons. Research indicates that these receptors are involved in the complex circuitry that regulates sleep and wakefulness. In the context of natural short sleep, the A187V mutation appears to alter the stability and activity of these receptors. Studies suggest that the mutation enhances the activity of wake-promoting neurons in the dorsal pons. By increasing the signaling that keeps the brain alert, the mutation effectively reduces the total amount of sleep required for the individual to feel restored, without the typical negative health consequences associated with sleep deprivation.
Evidence and Research Associations
The association between rs769049386 and natural short sleep is supported by clinical research, including studies of families who exhibit this lifelong sleep pattern. Affected individuals typically report sleeping 4 to 6 hours per night, compared to the 7 to 8 hours common in the general population. To validate these findings, researchers engineered mice with the same A187V mutation. These mice exhibited a similar phenotype, showing reduced sleep duration and increased activity during their wakeful periods. While the evidence linking this specific variant to the short-sleep trait is strong within the studied families, it remains a rare finding. The scientific community views this as a significant discovery in understanding the genetic basis of sleep regulation, though it is important to note that most sleep patterns are influenced by a wide variety of genetic and environmental factors.
Population Frequency and Clinical Context
The rs769049386 variant is classified as extremely rare, with a minor allele frequency reported as less than 0.00005 in large population databases like gnomAD. Because of its rarity, it is not a common cause of sleep variations in the general population. It is essential to understand that having this variant is not a medical diagnosis, nor is it a condition that requires treatment. Individuals who believe they have unusual sleep patterns should consult with a sleep specialist or healthcare provider to discuss their health, rather than relying on genetic data alone. Genetic information regarding sleep is an area of active research, and while variants like this provide insight into biological mechanisms, they do not dictate an individual's overall health or well-being. Always discuss any concerns about sleep quality or duration with a qualified clinician.
How common is this variant?
The rs769049386 variant is extremely rare in the general population, with a minor allele frequency of less than 0.00005 in gnomAD.
Frequently asked questions
What is familial natural short sleep?
Familial natural short sleep is a rare, inherited trait where individuals consistently sleep for only 4 to 6 hours per night. Despite this short duration, these individuals feel fully rested and do not experience the negative health effects typically associated with sleep deprivation.
Does the ADRB1 mutation cause insomnia?
No, the ADRB1 mutation associated with natural short sleep is distinct from insomnia. While insomnia involves difficulty falling or staying asleep and often results in daytime impairment, natural short sleepers are able to sleep efficiently and wake up feeling refreshed.
Can I get tested for the rs769049386 variant?
While this variant can be identified through whole-exome or whole-genome sequencing, it is not included in standard consumer genetic tests. If you have concerns about your sleep patterns, it is best to consult a sleep specialist rather than seeking genetic testing for this specific rare variant.
Is the ADRB1 mutation dangerous?
The research identified to date describes this mutation as a cause of a natural sleep phenotype rather than a disease. However, because ADRB1 is also involved in heart function, any genetic findings should be discussed with a medical professional who can provide context based on your overall health.
Sources & further reading
Educational information only, last refreshed 10/17/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs769049386?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants in ADRB1
The Ser49Gly missense polymorphism affects beta-1 adrenergic receptor downregulation, influencing heart rate response to exercise and pharmacological beta-blocker sensitivity.
A rare missense variant (p.Ala187Val) in the beta-1 adrenergic receptor gene ADRB1 linked to hereditary natural short sleep trait.
A rare variant in the ADRB1 gene linked to the natural short sleep trait in familial studies.
This SNP in the beta-1 adrenergic receptor gene is involved in catecholamine signaling, potentially influencing heart rate response and cardiovascular adaptation to aerobic exercise.